192 related articles for article (PubMed ID: 3975648)
1. Progestin therapy in lesions of the endometrium.
Wentz WB
Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
Gal D; Edman CD; Vellios F; Forney JP
Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
[TBL] [Abstract][Full Text] [Related]
4. Megestrol acetate in the management of advanced endometrial carcinoma.
Wait RB
Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
[No Abstract] [Full Text] [Related]
5. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
Rose PG
Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
[TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
[TBL] [Abstract][Full Text] [Related]
10. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
[TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate: clinical experience.
Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
[TBL] [Abstract][Full Text] [Related]
12. Use of progestational agents in endometrial adenocarcinoma.
Rozier JC; Underwood PB
Obstet Gynecol; 1974 Jul; 44(1):60-4. PubMed ID: 4834800
[TBL] [Abstract][Full Text] [Related]
13. Hormonal therapy for lesions of the endometrium.
Gal D
Semin Oncol; 1986 Dec; 13(4 Suppl 4):33-6. PubMed ID: 3798126
[TBL] [Abstract][Full Text] [Related]
14. Megestrol acetate for the palliation of advanced ovarian carcinoma.
Geisler HE
Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
[TBL] [Abstract][Full Text] [Related]
15. Progestin therapy in endometrial hyperplasia.
Wentz WB
Gynecol Oncol; 1974 Aug; 2(2-3):362-7. PubMed ID: 4457410
[No Abstract] [Full Text] [Related]
16. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
Kline RC; Freedman RS; Jones LA; Atkinson EN
Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
[No Abstract] [Full Text] [Related]
18. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
Shen ZQ; Zhu HT; Lin JF
Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
[TBL] [Abstract][Full Text] [Related]
19. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Mentrikoski MJ; Shah AA; Hanley KZ; Atkins KA
Am J Clin Pathol; 2012 Oct; 138(4):524-34. PubMed ID: 23010707
[TBL] [Abstract][Full Text] [Related]
20. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
Geisler HE
Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
